Rocket One Inc. Employee Stock Ownership Plan (ESOP), Compensation Expense
Rocket One Inc. (RKTO) reported Employee Stock Ownership Plan (ESOP), Compensation Expense of $700.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense · last filed 2021-03-16
- Rocket One Inc. employee stock ownership plan (esop), compensation expense for the quarter ending 2019-03-31 was $200.00K, a 1233.33% increase year-over-year.
- Rocket One Inc. employee stock ownership plan (esop), compensation expense for the quarter ending 2018-03-31 was $15.00K.
- Rocket One Inc. employee stock ownership plan (esop), compensation expense for fiscal 2020 was $700.00K, a 72.00% decline from fiscal 2019.
- Rocket One Inc. employee stock ownership plan (esop), compensation expense for fiscal 2019 was $2.50M, a 2400.00% increase from fiscal 2018.
- Rocket One Inc. employee stock ownership plan (esop), compensation expense for fiscal 2018 was $100.00K.
| Period end | Employee Stock Ownership Plan (ESOP), Compensation Expense 3 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 8 month | Employee Stock Ownership Plan (ESOP), Compensation Expense 12 month |
|---|---|---|---|
| 2020-12-31 | $700.00K 10-K · filed 2021-03-16 | ||
| 2019-12-31 | $2.50M 10-K · filed 2021-03-16 | ||
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-15 | ||
| 2018-12-31 | $100.00K 10-K · filed 2020-03-02 | ||
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-15 | ||
| 2017-12-31 | $1.00M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |